Table 1 |
||
|
Annual incidence probabilities of age-related macular degeneration for current smokers and ex-smokers who quit 15 years previously* |
||
| Type of age-related macular degeneration and age range |
Smoker (per 1000)† |
Quitter (per 1000)‡ |
|
|
||
| Neovascular |
||
| < 55 years |
0.00 |
0.00 |
| 55–64 years |
0.86 |
0.73 |
| 65–74 years |
4.50 |
3.84 |
| 75–84 years |
20.61 |
17.60 |
|
|
||
| Geographic atrophy |
||
| < 55 years |
0.00 |
0.00 |
| 55–64 years |
0.39 |
0.23 |
| 65–74 years |
1.86 |
1.11 |
| 75–84 years |
8.09 |
4.83 |
|
|
||
|
* Men and women combined † Estimated[4] from Beaver Dam Eye Study incidence data,[12] U.S. smoking prevalence in 2004–2005[10] and the relative risks of age-related macular degeneration for smokers and ex-smokers relative to never-smokers.[2] ‡ Estimated according to the relative risk functions plotted in Figure 2. |
||
|
Hurley et al. Cost Effectiveness and Resource Allocation 2008 6:18 doi:10.1186/1478-7547-6-18 |
||
